LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692 | -8.0% | 11,522 | +10.6% | 0.00% | – |
| Q2 2023 | $752 | +6.7% | 10,418 | +8.7% | 0.00% | – |
| Q1 2023 | $705 | +24.1% | 9,583 | +12.8% | 0.00% | – |
| Q4 2022 | $568 | -99.9% | 8,496 | +2.6% | 0.00% | – |
| Q3 2022 | $713,000 | +14.3% | 8,277 | +18.4% | 0.00% | – |
| Q2 2022 | $624,000 | -31.7% | 6,993 | -14.0% | 0.00% | – |
| Q1 2022 | $914,000 | -21.1% | 8,128 | +8.3% | 0.00% | – |
| Q4 2021 | $1,159,000 | -4.8% | 7,502 | -14.2% | 0.00% | – |
| Q3 2021 | $1,218,000 | -0.9% | 8,746 | -6.6% | 0.00% | – |
| Q2 2021 | $1,229,000 | -21.3% | 9,366 | -8.6% | 0.00% | – |
| Q1 2021 | $1,562,000 | -75.4% | 10,245 | -83.9% | 0.00% | -100.0% |
| Q4 2020 | $6,347,000 | -62.3% | 63,818 | -63.8% | 0.00% | -50.0% |
| Q3 2020 | $16,824,000 | -49.2% | 176,501 | -40.4% | 0.00% | -50.0% |
| Q2 2020 | $33,119,000 | +42.2% | 296,104 | -7.6% | 0.00% | 0.0% |
| Q1 2020 | $23,294,000 | -32.8% | 320,322 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $34,663,000 | +2.0% | 332,375 | -2.7% | 0.00% | -20.0% |
| Q3 2019 | $33,991,000 | -13.5% | 341,485 | -0.8% | 0.01% | -16.7% |
| Q2 2019 | $39,309,000 | -8.8% | 344,362 | +0.4% | 0.01% | 0.0% |
| Q1 2019 | $43,105,000 | -5.3% | 342,890 | +2.2% | 0.01% | -25.0% |
| Q4 2018 | $45,526,000 | -45.5% | 335,493 | +10.3% | 0.01% | -33.3% |
| Q3 2018 | $83,477,000 | +38.4% | 304,115 | +4.5% | 0.01% | +33.3% |
| Q2 2018 | $60,300,000 | +34.0% | 291,067 | +6.8% | 0.01% | +28.6% |
| Q1 2018 | $45,007,000 | +27.3% | 272,507 | +5.6% | 0.01% | +16.7% |
| Q4 2017 | $35,346,000 | +6.9% | 258,134 | +6.3% | 0.01% | 0.0% |
| Q3 2017 | $33,061,000 | +18.3% | 242,827 | +5.5% | 0.01% | +20.0% |
| Q2 2017 | $27,948,000 | +19.9% | 230,217 | +4.6% | 0.01% | +25.0% |
| Q1 2017 | $23,301,000 | -50.5% | 220,150 | -52.5% | 0.00% | -55.6% |
| Q4 2016 | $47,109,000 | -11.9% | 463,626 | -11.6% | 0.01% | -18.2% |
| Q3 2016 | $53,502,000 | -11.4% | 524,217 | +3.6% | 0.01% | -15.4% |
| Q2 2016 | $60,373,000 | +14.8% | 506,188 | +3.1% | 0.01% | +18.2% |
| Q1 2016 | $52,573,000 | +1.2% | 490,928 | +2.5% | 0.01% | 0.0% |
| Q4 2015 | $51,932,000 | +30.5% | 478,988 | +3.1% | 0.01% | +22.2% |
| Q3 2015 | $39,805,000 | -14.8% | 464,738 | +0.4% | 0.01% | -10.0% |
| Q2 2015 | $46,721,000 | +530.9% | 463,038 | +382.1% | 0.01% | +400.0% |
| Q1 2015 | $7,405,000 | +60.8% | 96,038 | +11.0% | 0.00% | +100.0% |
| Q4 2014 | $4,605,000 | +5.8% | 86,538 | -6.6% | 0.00% | 0.0% |
| Q3 2014 | $4,353,000 | -23.2% | 92,638 | +1.8% | 0.00% | 0.0% |
| Q2 2014 | $5,671,000 | +4.0% | 91,038 | +12.3% | 0.00% | 0.0% |
| Q1 2014 | $5,451,000 | -21.4% | 81,038 | -38.5% | 0.00% | 0.0% |
| Q4 2013 | $6,936,000 | +1480.0% | 131,876 | +1200.8% | 0.00% | – |
| Q3 2013 | $439,000 | -35.8% | 10,138 | -44.5% | 0.00% | – |
| Q2 2013 | $684,000 | – | 18,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |